NCT00084552View on ClinicalTrials.gov

Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer

NACompletedINTERVENTIONAL

Enrollment

116

Participants

Timeline

Start Date

December 11, 2003

Primary Completion Date

August 24, 2013

Study Completion Date

May 5, 2016

Conditions

Prostate CancerSexual DysfunctionSexuality and Reproductive Issues

Interventions

RADIATION

radiation therapy

Patients undergo conventional intensity-modulated radiotherapy (IMRT) once daily 5 days a week for approximately 7.5 weeks.

Trial Locations (1)

19111-2497

Fox Chase Cancer Center - Philadelphia, Philadelphia

All Listed Sponsors

lead

Fox Chase Cancer Center

OTHER

NCT00084552 - Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer | Biotech Hunter | Biotech Hunter